Page last updated: 2024-10-28

1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Experimental Spinal Cord Ischemia

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Experimental Spinal Cord Ischemia in 2 studies

1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohbuchi, M1
Kimura, T1
Nishikawa, T1
Horiguchi, T1
Fukuda, M1
Masaki, Y1
Baba, H1
Tanoue, Y1
Maeda, T1
Kobayashi, M1
Oda, S1
Tominaga, R1

Other Studies

2 other studies available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Experimental Spinal Cord Ischemia

ArticleYear
Neuroprotective Effects of Fasudil, a Rho-Kinase Inhibitor, After Spinal Cord Ischemia and Reperfusion in Rats.
    Anesthesia and analgesia, 2018, Volume: 126, Issue:3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Administration, Intravenous; Animals; Male; Neuroprot

2018
Protective effects of cold spinoplegia with fasudil against ischemic spinal cord injury in rabbits.
    Journal of vascular surgery, 2010, Volume: 51, Issue:2

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Anterior Horn Cells; Aorta; Constriction; Di

2010